Wyeth Is Warned on Quality Control at Plant
From Reuters
Possible contaminants in headache remedies, hormone replacement therapy and other pills made at Wyeth’s plant in Puerto Rico have not been adequately checked or corrected, the U.S. Food and Drug Administration said.
The warning came on top of a Merrill Lynch & Co. downgrade of Wyeth to “neutral” from “buy.” Wyeth shares fell $1.55 to $46.32.
